Using data to outpace disease
We created the Biofourmis platform to solve challenges impacting healthcare today—from staffing shortages to the prevalence of certain chronic conditions to the need for developing drugs that address common treatment complexities. Our configurable technology and services span the care continuum, enabling dynamic care pathways designed to deliver individualized, timely, data-driven interventions for every patient.
Data
Collect and Aggregate
Through biosensor data collection, we use vital signs to create unique and aggregate biomarkers that continuously represent the clinical status of the patient.

ANALYTICS
Detect and Predict
Our FDA-cleared algorithms generate a personalized baseline for each patient and detect clinical deviation. By recognizing clinically meaningful fluctuations, our AI-driven analytics can predict deterioration early, so that it can be proactively addressed.

INTERVENTIONS
Treat and Track
Our platform facilitates personalized clinical interventions through a user-friendly dashboard, communication interface, and resource coordination. Dynamic care pathways are designed to improve outcomes by managing each patient according to disease, acuity level, and clinical goals. Collectively, these tools help manage, escalate, and track timely care during clinically significant events, virtually and in-person.

INNOVATION and OUTCOMES
Care and Connect
Our AI-guided algorithms continuously learn and adjust, so that patients receive the right care at the right time. Technology-enabled remote and in-home support includes care coordination, nursing, and diagnostics—all configurable to augment your organization’s needs to deliver personalized care across the care continuum, from drug development to care delivery.

digital biomarkers
patient data points in our data lake1
dynamic remote care pathways1
Making home the site of care
Our technology-enabled solutions empower patients to receive care at home, and easily transition between levels and locations of care. Outcomes have shown clinical, operational, and economic improvements such as a 70% reduction in 30-day readmissions, the ability to detect deterioration 21 hours sooner, and reductions in cost of care by up to 38%2,3.
.webp)

Connecting drug development to care delivery
We enable life science companies to deliver clinical trials anywhere, and to commercialize novel therapies and digital health products*.
Our collaborators in the healthcare-delivery revolution
















































News & Insights
1. Biofourmis data on file.
2. Un, KC., Wong, CK., Lau, YM. et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11, 4388 (2021). https://doi.org/10.1038/s41598-021-82771-7.
3. Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
*Subject to geography and connectivity